N euroimaging plays a central role in the evaluation of patients suspected of acute ischemic stroke. Because of significant advances during the past decade, imaging now provides information beyond the mere presence or absence of intracranial hemorrhage. Multimodal cerebrovascular computed tomography (CT) imaging protocols, including parenchymal imaging (noncontrast head CT [NCT]), vascular imaging (CT angiography [CTA]), and perfusion/penumbral imaging (perfusion CT [PCT]), can be acquired within minutes, providing information about tissue viability, site of occlusion, and collateral status. In particular, PCT can rapidly generate quantitative and qualitative parameters describing cerebral perfusion that enable discrimination between normal, ischemic but salvageable (ischemic penumbra), and infarcted tissue. As several sites have started using these multimodal protocols as part of their routine acute stroke patient workup, the concept of "time is brain" in stroke reperfusion treatment has been challenged by those of "pathophysiology is brain" 1 and "imaging is brain."
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However, there is no consensual agreement in the stroke community that perfusion/penumbral imaging is needed or even useful. There is still insufficient evidence that treatment decisions based on perfusion imaging improve clinical outcome in acute ischemic stroke patients, and the concept of penumbral image-guided thrombolytic therapy remains to be validated in a large phase III trial. 3, 4 As a result, PCT has not become part of the clinical standard-of-care in reperfusion decisions. Several experts think that NCT and CTA combined with clinical information provide sufficient information about tissue fate and outcome. [5] [6] [7] [8] [9] The goal of our study was to determine whether PCT adds value to NCT, CTA, and clinical assessment in patients suspected of acute ischemic stroke in a large registry of stroke patients who were systematically imaged using NCT, PCT, and CTA. More specifically, we assessed (1) whether the infarct and penumbral information extracted from PCT can be inferred from NCT, CTA, and clinical characteristics, or whether it constitutes independent and unique information; and (2) whether PCT penumbral information is an independent predictor of clinical outcome measured as modified Rankin score (mRS) at 3 months, beside NCT, CTA, and clinical characteristics.
Materials and Methods
Patients
The clinical and imaging data presented in this study belong to a repository created from the data collected as part of the standard clinical stroke care at 2 participating institutions: the University of Pittsburgh Medical Center, Pittsburgh, PA, and the Center Hospitalier Universitaire Vaudois, Lausanne, Switzerland. Only completely anonymized data, stripped of Health Insurance Portability and Accountability Act of 1996 (HIPPA) information, were contributed to the repository. Collection and analysis of data from the repository were approved by the respective institutional review boards of the 3 contributing institutions (UVA, UPMC and CHUV institutional review boards).
At these institutions, patients with symptoms suggestive of acute stroke and no contraindications to intravenous-iodinated contrast routinely undergo a stroke CT imaging workup that includes a NCT, PCT, and CTA of the cervical and intracranial vessels.
We retrospectively identified all consecutive patients admitted to these institutions with signs and symptoms, suggesting hemispheric stroke from January 2003 to June 2011, who met the following inclusion criteria: (1) acute ischemic stroke with internal carotid artery and/or M1 occlusion, without evidence of intracerebral hemorrhage; (2) completion of a stroke CT workup, including NCT, PCT, and CTA on admission; (3) time from onset to imaging was <12 hours; and (4) completion of recanalization imaging between 1 and 48 hours, consisting of either CTA, magnetic resonance angiography, and digital subtraction angiography.
The following demographic and clinical variables were recorded: age, sex, type of reperfusion therapy (if any), time from symptom onset to baseline imaging, time from baseline imaging to reperfusion therapy, time from baseline imaging to recanalization imaging, National Institutes of Health Stroke Scale (NIHSS) on admission, and mRS at 90 days. Ninety-day outcomes were assessed in an outpatient clinic or over the telephone. Death was coded as mRS=6.
PCT and CTA Image Acquisition
PCT studies were obtained on 16-and 64-slice CT scanners. Each PCT study involved successive gantry rotations performed in cine mode during intravenous administration of 1 or 2 boluses of 40 to 50 mL of iodinated contrast material at an injection rate of 4 to 5 mL/s. First-pass PCT acquisition ranged from 50 to 70 seconds, with a sampling interval of either 1 or 2 seconds. Total PCT coverage ranged from 20 to 80 mm. Acquisition parameters were 80 kVp and 100 to 200 mAs.
The CTA studies of the cervical and intracranial arteries were obtained with an image acquisition protocol as follows: helical mode, 0.5 to 0.8 second gantry rotation; pitch, 1 to 1.375:1; slice thickness, 0.625 to 1.25 mm; reconstruction interval, 0.5 to 1 mm; and acquisition parameters, 120 kVp/200 to 300 mAs. A caudocranial scanning direction was selected covering the midchest to the vertex of the brain.
Image Processing and Interpretation
Images were transferred to a Mac Pro workstation (Apple, Cupertino, CA).
A neurologist (G.Z.) with 11 years of experience reviewed the NCT images using Osirix v 3.7.1 (Pixmeo, Geneva, Switzerland). He calculated the Alberta Score Program Early CT Score (ASPECTS) and assessed the presence or absence of hyperdense middle cerebral artery CT sign. He was blinded to the initial clinical interpretation of these studies, to the type of treatment received by each patient, and to the success of this treatment, or lack thereof, in terms of recanalization. He was provided only with the body side of the signs and symptoms.
A neuroradiologist (M.W.) with 13 years of experience reviewed the head and neck CTA images to evaluate the site and grade of arterial occlusion, to characterize the collateral circulation, and to assess the degree of cervical internal carotid artery stenosis. The site of occlusion was recorded as internal carotid artery only, M1 only, or both. The grade of arterial occlusion was scored by using a modified thrombolysis in myocardial ischemia scheme: 0=com-plete occlusion, 1=severe stenosis, 2=mild or moderate stenosis, and 3=normal. Recanalization imaging, which consisted either of CTA, magnetic resonance angiography, or digital subtraction angiography, was reviewed for a second thrombolysis in myocardial ischemia measurement. Recanalization was defined as an improvement in the thrombolysis in myocardial ischemia score from baseline to recanalization of ≥2 points.
Absence of collateral flow to the ischemic territory was graded as 0, whereas contrast filling of the arterial segments distal to the occlusion in the ischemic territory on CTA was graded as collateral flow of 1, 2, or 3, respectively; a score of 4 was added for individuals with >100% filling of the ischemic bed when compared with the normal side, reflecting hyperemia of the ischemic territory. 10 North American Symptomatic Carotid Endarterectomy Trial criteria were used to quantify the degree of cervical carotid stenosis.
The PCT data were analyzed using Philips Brain Perfusion software version 4.5.2 (Philips Medical Systems, Cleveland, OH). This software relies on the central volume principle. The software applies curve fitting by least mean squares to obtain mathematical descriptions of the time-density curves for each pixel. The radiologist selects an arterial input function and a venous output, and a closed-form deconvolution is then applied to create a mean transit time map.
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The cerebral blood volume map is calculated from the area under the time-density curves. The software calculates the PCT-predicted infarct core (PCT infarct) and at-risk ischemic tissue (penumbra, PCT penumbra) using validated mean transit time and cerebral blood volume thresholds (mean transit time > 145% of the contralateral side values and cerebral blood volume < 2.0 mL/100g to define PCT infarct; mean transit time > 145% of the contralateral side values and cerebral blood volume > 2.0 mL/100g to define PCT penumbra). 12 The volumes of PCT infarct and PCT penumbra, automatically measured by the software, were recorded.
Statistical Analysis
Descriptive Statistics
Continuous scaled data (eg, age, PCT infarct, and PCT penumbra) were summarized by the mean±SD of the measurement distribution and by the range of the measurement distribution. Frequency data (eg, sex) were summarized by counts and percentages. 
Analysis 1
The objective of analysis 1 was to determine whether PCT infarct and PCT penumbra can be predicted from clinical, NCT and CTA variables. Multivariate ordinary least squares regression was used. PCT infarct volume and PCT penumbra volume represented the 2 ordinary least squares regression outcomes variables (ie, dependent variables). For each outcome variable, the ordinary least squares regression predictor variables included age, sex, NIHSS at admission, time from symptom onset to baseline imaging, ASPECTS, hyperdense middle cerebral artery CT sign, collateral flow, site of occlusion, and North American Symptomatic Carotid Endarterectomy Trial. The primary aim of the hypothesis testing procedure was to examine the relative importance of the different components of the workup (ie, the clinical, NCT, and CTA components) in predicting outcome, more so than to examine the relative importance of the individual predictors. Hypothesis testing was conducted in a hierarchical manner to reduce the chance of false discovery due to conducting multiple tests. For each ordinary least squares regression analysis, a global hypothesis test was first conducted to determine whether the total variability in the outcome data explained by the complete set of the components of workup was in excess of the amount of variation in the outcome data that would be expected to be explained by these predictors purely by chance. If the global hypothesis test was rejected based on a P≤0.05 decision rule, then we tested whether the total variability in the outcome data uniquely explained by the clinical variables, the NCT variables (ASPECTS and hyperdense middle cerebral artery CT sign), and the CTA variables (site of occlusion, collateral flow, and North American Symptomatic Carotid Endarterectomy Trial) was important in predicting outcome. Extra sum of squares F tests were used to conduct the aforementioned hypothesis tests. A P≤0.05 decision rule was used as the null hypothesis rejection rule. Akaike information criterion was used to determine the set of components that best predict outcome. The ols function of the Spotfire Splus 8.2 statistical package (TIBCO Inc., Palo Alto, CA) was used to conduct the aforementioned analyses.
Analysis 2
The objective of analysis 2 was to determine whether significant predictive information about clinical outcome (90-day mRS) is gained by knowing PCT infarct and PCT penumbra in addition to knowing clinical, NCT, CTA, and other information. Multivariate logistic regression (MLR) was used. A binary variable Y, which dichotomized the patients into 2 groups according to whether the patient had a good outcome (ie, Y=1, if mRS=0-2) or a poor outcome (ie, Y=0, if mRS>2), represented the dependent variable (ie, outcome variable) in the MLR analysis. The regression model predictor variables included clinical variables, NCT variables, PCT variables, CTA variables, treatment, and recanalization. In addition, PCT coverage was included as a predictor/confounding variable, and a PCT penumbra by recanalization interaction term was included in the MLR model to examine whether the strength and the direction of the association between penumbra and clinical outcome were influenced by recanalization status. The same underlying rational was the bases for including a collateral flow by recanalization interaction term and treatment by recanalization interaction term in the MLR model. The hypothesis testing procedure was conducted in a hierarchical manner. Likelihood ratio tests were first conducted to determine whether any of the aforementioned components were uniquely associated with clinical outcome after taking into consideration the predictive information shared by multiple components. As the second step in the hypothesis testing process, if the information provided by a component (eg, NCT data) was determined to be uniquely associated with clinical outcome at P≤0.05, then an additional set of likelihood ratio tests was conducted to determine which variables within the component set were uniquely associated with clinical outcome at P≤0.05. The workup component rankings were established based on the magnitude of the difference between the observed value of the likelihood ratio statistic and the expected value of the likelihood ratio statistic when the null hypothesis is true. Variable rankings within those components found to be significant at P≤0.05 were established by the same method. The 
Results
Patient Population
We identified 165 patients (women 49.7%; 82/165) matching our inclusion criteria. Table 1 . Missing data included 4 cases missing the time from onset to reperfusion therapy, 7 cases missing the time from onset to recanalization images, and 1 case missing North American Symptomatic Carotid Endarterectomy Trial data. Also, 20 patients did not receive treatment; for these patients, time from onset to reperfusion therapy could evidently not be calculated.
PCT Infarct and Penumbra
On the admission PCT, the mean infarct volume was 44.6±46.8 mL (range, 0-264.9 mL). Mean PCT penumbra volume was 47.2±34.0 mL (range, 0-235.6 mL).
On an important note, the respective volumes of infarct and penumbra at the time of PCT were independent of each other (Figures 1 and 2) . In other words, for a set volume of infarct, the volume of penumbra was highly variable (Figure 1) . Also, for a set total volume of ischemia (infarct core penumbra), the relative proportion of infarct and penumbra was highly variable ( Figure 2 ).
Analysis 1:
Whether PCT Infarct and PCT Penumbra (Outcomes) Can Be Predicted From Clinical, NCT, and CTA PCT infarct volume was uniquely associated with clinical data (admission NIHSS) (P<0.001), NCT data (P=0.007), and CTA data (P=0.013). Not surprisingly, the full regression model with the entire set of predictors from all 3 components of workup (clinical, NCT, and CTA) produced the best model (P<0.001) ( Table 2) .
However, PCT penumbra volume could not be predicted by either clinical data, NCT data, CTA data, or a combination thereof (P=0.094).
Analysis 2: Whether Significant Predictive Information About Clinical Outcome (90-day mRS) Is Gained by Knowing PCT Infarct and PCT Penumbra in Addition to
Knowing Clinical, NCT, and CTA Information Of the 165 study patients, 76 (46.1%) had a good outcome (ie, 90-day mRS from 0 to 2). Eighty-nine (53.9%) patients had a poor outcome (ie, 90-day mRS>2) ( Table 3) .
The clinical data (P<0.001), the PCT data (P=0.009), and the postworkup treatment and recanalization data (P=0.001) were significantly associated with 90-day mRS outcome (Table 4) . Neither the NCT component nor the CTA component was significantly associated with 90-day mRS outcome Perfusion computed tomography-based volumes of infarct core (red) and penumbra (green) in our 165 patients, sorted by volume of PCT ischemia (infarct core+penumbra). For a set total volume of ischemia (infarct+penumbra), the relative proportion of infarct and penumbra is highly variable.
by guest on April 10, 2017 http://stroke.ahajournals.org/ Downloaded from (P=0.577 and P=0.224, respectively). The single most important predictor was recanalization status (P<0.001). Significant clinical variables included age (P<0.001) and baseline NIHSS (P=0.004). PCT penumbra volume was also a significant predictor of 90-day mRS outcome (P=0.001), and the strength and the direction of the association between 90-day mRS outcome and PCT penumbra volume were recanalization status dependent (P<0.001). Adjusted odds ratios are provided in the Table in the online-only Data Supplement for the significant predictor variables.
Discussion
Penumbral imaging-guided selection of acute ischemic stroke patients for reperfusion therapy might significantly increase the fraction of acute stroke patients amenable to thrombolytic treatment, possibly up to 40%, by extending the therapeutic time window. However, few studies have been able to show that penumbral identification by PCT or any other technique actually changes patient outcomes. The Buffalo Stroke Group concluded that careful PCT imaging-based selection of patients outside the traditional treatment time window is safe, effective, and improves clinical outcome. 13 But patients in this cohort were not compared with a control group of patients treated without being assessed by perfusion/penumbral imaging. Other studies, such as the one by Hassan et al, 14 found no increased clinical benefit with respect to functional outcome, early neurological improvement, intracranial hemorrhage, or in-hospital mortality in the imaging-based group. These observations have led some to postulate that a stroke imaging workup, including only parenchymal and vascular imaging (such NCT and CTA) without perfusion/penumbral imaging, is sufficient, based on the assumption that penumbra information can be inferred from various combinations of clinical information and NCT and CTA findings. [6] [7] [8] In our large series of patients, we found that PCT infarct core can indeed be inferred from clinical, NCT, and CTA data, or various combinations thereof. There was a good correlation between NIHSS score and infarct core size. There was also a good correlation between PCT infarct core and ASPECTS on NCT, and between PCT infarct core and site of occlusion and collateral score on CTA. This is in agreement with what is reported in the literature. Tong et al 15 reported that 24-hour NIHSS Score is highly correlated with lesion volume not only on perfusion-weighted imaging but also on diffusion-weighted Akaike information criterion (AIC) is a relative measure of goodness of fit. By systematically excluding variables from the full model, AIC can be used to rank the performance of all submodels (ie, reduced models) as well as the full model. AIC favors parsimony compared with complexity by penalizing for the number of model parameters. Models that produce a small AIC value are preferred compared with models that produce a large AIC value. Note that for PCT penumbra, the global hypothesis test pertaining to the complete set of predictor variables in the full model failed to be rejected. Hence, no additional hypothesis tests were conducted. Note that LR statistics and probability values are adjusted for all other predictor versus outcome variable associations.
AIC indicates Akaike information criterion; CTA, computed tomography angiogram; LR, likelihood ratio; NCT, noncontrast head computed tomography; and PCT, perfusion computed tomography. 16 CTA and CTA source images, which include information on the site of occlusion and collateral flow, were shown to be able to provide information correlated with lesion volume on diffusion-weighted imaging. 17 Of note, the significant association of NCT, CTA, and clinical variable with PCT infarct core volume does not mean that there is no additional information gained from PCT infarct core assessment.
On the contrary, PCT penumbral information could not be inferred from clinical, NCT, and CTA data, or various combinations thereof. In other words, PCT penumbra was not correlated with ways that were previously reported as indicative of tissue at risk, such as ASPECTS-NIHSS mismatch (ASPECTS corresponds to infarct core, whereas NIHSS reflects the total ischemic area) 18, 19 or site of occlusion-ASPECTS mismatch (ASPECTS corresponds to infarct core, whereas the site of occlusion defines the total vascular territory that is ischemic). 17, 20, 21 Also, CTA collateral status 9, 22, 23 was probably too coarse of a description to match favorably with continuous penumbral volume measurement by PCT.
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Our data also show clearly that there is no simplistic relationship between site of occlusion, infarct core, and penumbra. For the same site of occlusion (internal carotid artery and/ or M1), the volume of penumbra was highly variable for a set volume of infarct. Also, for a set total volume of ischemia (infarct core+penumbra), the relative proportion of infarct and penumbra was highly variable. This likely reflect the fact that for the same degree of compromise of the antegrade flow, the degree of retrograde flow through the collateral circulation is highly variable, resulting in variable amounts of infarct core and penumbra.
Although our first analysis demonstrated that PCT penumbra constituted unique information, our second analysis confirmed that the unique information provided by PCT penumbra is clinically relevant in terms of predicting clinical outcome. In our study population, PCT penumbra was one of the independent predictors of 90-day mRS, in addition to age, NIHSS, and site of occlusion. Interestingly, penumbra was a hallmark of positive outcome only in the presence of recanalization, whereas it was associated with worst outcome in the absence of recanalization. This is in agreement with previous reports using magnetic resonance angiography imaging. 25, 26 We acknowledge some limitations to our study. Because of its retrospective nature, our study was limited by the variability of the imaging modalities to assess recanalization (CTA, magnetic resonance angiography, and digital subtraction angiography). Also, because of our selection of patients with internal carotid artery and/or M1 occlusion, and because of the time window for the initial CT workup (0-12 hours), the sensitivity reported for CTA and especially NCT may be higher than in an unselected stroke population imaged within a 3-or 4.5-hour time window. Our reasoning was that the most conservative approach was to consider a homogenous population of stroke patients in whom NCT and CTA performed optimally. If we could show an added value of PCT in this selected population where NCT and CTA are highly sensitive, Rankings were established based on the magnitude of the difference between the observed value of the LR statistic and the expected value of the LR statistic when the null hypothesis is true.
-indicates that the component to which the predictor variable belongs was not found to be statistically associated with 90-day mRS outcome at P≤0.05. Note that the LR statistics and the probability values are adjusted for all other predictor versus outcome variable associations. ASPECTS indicates Alberta Score Program Early CT Score; CT, computed tomography; CTA, computed tomography angiogram; LR, likelihood ratio; mRS, modified Rankin score; NCT, noncontrast head computed tomography; NIHSS, National Institutes of Health Stroke Scale; and PCT, perfusion computed tomography.
*Simultaneous test that regression coefficients associated with collateral flow and collateral flow by recanalization interaction are both equal to 0. †Simultaneous test that regression coefficients associated with PCT penumbra and PCT penumbra by recanalization interaction are both equal to 0. ‡Simultaneous test that the regression coefficients associated with treatment type and treatment type by recanalization interaction are both equal to 0. §Simultaneous test that regression coefficients associated with recanalization, PCT penumbra by recanalization interaction, collateral flow by recanalization, and treatment by recanalization are all equal to 0.
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In summary, our study demonstrates that the PCT component of a stroke CT workup adds value and provides unique and clinically relevant information compared with clinical data, NCT, and CTA. More generally, penumbra imaging seems as an important element of the initial evaluation of acute ischemic stroke patients, in addition to parenchymal and vascular imaging. Prospective studies are needed to validate the role of PCT penumbral assessment in the selection of acute ischemic stroke patients for reperfusion therapy.
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